CMS NEWS
FOR IMMEDIATE RELEASE
October 31, 2019
Contact: CMS Media
Relations
(202) 690-6145 | CMS Media Inquiries
Trump Administration Delivers on Promise to Strengthen Medicare
with a New Home Infusion Therapy Benefit and Home Health Regulations that Put
Patients Over Paperwork
New Home Health Prospective Payment System responds to unique needs of patients and reduces burden on providers.
Today, consistent with the
direction of President Trump’s Executive Order on Protecting and Improving
Medicare for Our Nation’s Seniors, the Centers for Medicare & Medicaid
Services (CMS) finalized significant changes to the Home Health Prospective
Payment System (HH PPS), including a new home infusion therapy benefit that
builds on the historic steps we have already taken to strengthen and protect
the Medicare program by increasing choices and empowering patients. The final
rule with comment period implements the Executive Order by eliminating
burdensome requirements of the Medicare program that are more stringent than
applicable Federal or State laws for maintenance therapy. The final rule with
comment period also increases Medicare payments to home health agencies
(HHAs) by an estimated 1.3 percent ($250 million) for calendar year (CY)
2020.
“The Trump Administration
is committed to bold and comprehensive healthcare policies that respond to
the individual needs of patients. The new permanent home infusion therapy
benefit increases the availability of home based care, by giving patients the
choice and convenience to receive critical treatments, such as anti-infectives
and chemotherapy, safely at home instead of a hospital or doctor’s office,”
said CMS Administrator Seema Verma. “Today’s final rule also rewards value
over volume by focusing on patient information such as their diagnosis and
other health conditions, to more accurately pay for home health services.”
Today’s final rule with
comment period will provide a permanent home infusion therapy benefit to be
implemented beginning in 2021, as required by the 21st Century
Cures Act. Home infusion therapy is the administration of certain types of
medication, through a durable medical equipment (DME) pump, in the patient’s
home. The home infusion therapy benefit includes: professional services,
including nursing; patient education and training; and patient monitoring for
the provision of home infusion therapy. In response to public feedback, CMS
is also soliciting comments on options to enhance future efforts to improve
policies related to coverage of eligible drugs for home infusion therapy.
In response to public feedback
received under our Patients Over Paperwork initiative and as part of the
Executive Order and the Trump Administration’s efforts to cut the red tape,
CMS is modifying its regulations to allow therapist assistants—rather than
only therapists—to perform maintenance therapy under the Medicare home health
benefit, in accordance with individual state practice requirements. This
change allows therapist assistants to utilize all of the skills under their
license and gives HHAs the opportunity to use both therapists and therapist
assistants to perform maintenance therapy. This ensures that HHAs have enough
staff available to provide the appropriate amount of therapy to their
patients, improving beneficiary access to these services.
CMS is implementing the
Patient-Driven Groupings Model (PDGM), a new case-mix payment methodology for
home health services, which more accurately pays for home health services and
focuses on patient needs by relying heavily on patient characteristics rather
than volume of care. CMS is finalizing a CY 2020 30-day payment amount for
those HHAs that report the required quality data of $1,864.03, which is 4
percent higher than the proposed CY 2020 30-day payment amount of $1,791.73
as a result of a modification to our proposed adjustment, for the initial
year of the PDGM, that is associated with behavior change assumptions.
CMS is addressing
potential Medicare fraud by phasing out pre-payments for home health services
over the next year and eliminating those payments completely in 2021.CMS has
seen a marked increase in Request for Anticipated Payment (RAP) fraud schemes
perpetuated by existing HHAs that receive significant upfront payments, then
never submit final claims and close for business, making Medicare recoupment
efforts impossible. CMS believes that eliminating RAP payments over the next
two years would serve to mitigate potential fraud schemes while minimally
impacting HHAs due to implementation of the PDGM, which increases the
frequency of payments for services to HHAs.
The final rule with
comment period can be downloaded from the Federal
Register at: https://www.federalregister.gov/documents/2019/11/08/2019-24063/medicare-program-end-stage-renal-disease-prospective-payment-system-payment-for-renal-dialysis
For a fact sheet on
today’s final rule with comment period, please visit: https://www.cms.gov/newsroom/fact-sheets/cms-finalizes-calendar-year-2020-payment-and-policy-changes-home-health-agencies-and-calendar-year
For additional information
about the Home Health Prospective Payment System, visit https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/HomeHealthPPS/index.html
and https://www.cms.gov/center/provider-Type/home-Health-Agency-HHA-Center.html.
For additional information
about the Home Health Patient-Driven Groupings Model, visit https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/HomeHealthPPS/HH-PDGM.html
For additional information
about the Home Infusion Therapy benefit, visit - https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/Home-Infusion-Therapy/Overview.html
For additional information
about the Home Health Quality Reporting Program, visit https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/HomeHealthQualityInits/Home-Health-Quality-Reporting-Requirements.html
For additional information
about the Home Health Value-Based Purchasing (HHVBP) Model, visit: https://innovation.cms.gov/initiatives/home-health-value-based-purchasing-model
###
Get CMS news at cms.gov/newsroom, sign up for CMS news via email and follow CMS on Twitter CMS
Administrator @SeemaCMS, @CMSgov, and @CMSgovPress.
|
|
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Thursday, October 31, 2019
Trump Administration Delivers on Promise to Strengthen Medicare with a New Home Infusion Therapy Benefit and Home Health Regulations that Put Patients Over Paperwork
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment